메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류
인문학
인문학 일반 역사학 철학 종교학 어문학 기타 인문학
사회과학
사회과학 일반 경영학 관광학 교육학 군사학 문헌정보학 법학 사회학 신문방송학 심리과학 정치외교학 지리학 행정학 경제학 무역학 인류학 기타 사회과학
자연과학
자연과학 일반 물리학 생물학 생활과학 수학·통계학 천문학 지구과학 화학 기타 자연과학
공학
공학 일반 건축공학 기계공학 산업공학 재료·에너지공학 전기전자공학 조선해양공학 화학공학 컴퓨터학 기타공학
의약학
의학 일반 간호학 수의학 약학 한의학 기초의학 임상의학 기타 의약학
농수해양학
농수해양학 일반 농학 수산학 식품과학 임학 축산학 해상운송학 기타 농수해양학
예술체육학
예술 일반 디자인 미술 미용 사진 음악학 의상 체육 공연매체예술 기타 예술체육학
복합학
학제간연구 과학기술학 뇌인지과학 기술정책 기타 복합학

ENG

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국비교정부학회 한국비교정부학보 한국비교정부학보 제23권 제3호
발행연도
2019.1
수록면
135 - 168 (34page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Europe, together with United States, has led the growth of the pharmaceutical industry around the world. However, some criticized that principle of competition did not work well due to the structural and regulatory characteristics of the pharmaceutical industry. In 2009, the EU Commission conducted sector inquiry on the pharmaceutical industry and reviewed various legal issues in the perspective of the EU competition rules. After the sector inquiry, EU competition authorities have actively enforced their competition rules on the pharmaceutical industry and have actively prepared and implemented competition policies for the industry. Finally, at the request of the EU Parliament and the EU Council, the EU Commission recently submitted a report which includes representative cases and relevant statistics of EU competition authorities on the pharmaceutical industry. Because the industry size is very large and lots of dominant companies have been existed, violations of competition rules have been occurred in various forms and ways. In the perspective of comparative law and comparative administration, it is highly valuable to research about how the EU competition rules, which has played a major role in the global competition law with the United States, has addressed the behaviors. However, since the KFTC published the competition policy report on pharmaceutical industry in 2009, there have been few studies in Korea which reviewed competition law enforcement of EU competition authorities on the pharmaceutical industry. Therefore, this article reviews the recent report of the EU Commission and tries to find implications on the enforcement of MRFTA and relevant competition policy. First, regarding the antitrust enforcement, it seems that the KFTC have mainly focused on rebate issue in the pharmaceutical industry. It is time for the KFTC to review other type of violations which the EU competition authorities have regulated, such as misuse of patent system and other regulatory frameworks for preventing generic companies from entering the market, disparagement the quality or safety of generic drugs for preventing generic companies from entering the market, and the excessive pricing by the original companies. Also, regarding the merger regulation, it is necessary for the KFTC to carefully review the concerns about innovation competition in merger cases involving the industry and find the best remedies through sufficient consultation with the merging entities. For this, experiences of the EU competition authorities on the innovation competition in merger cases of pharmaceutical companies would be great helpful. Additionally, regarding the competition policy, market monitoring about the pharmaceutical industry should be carried out more regularly by the KFTC with reference to the experience of EU competition authorities. Finally, it is necessary for the KFTC to check loopholes in other regulations related to the pharmaceutical industry from the perspective of competition law through competition advocacy activities.
#EU Competition law #Pharmaceutical Industry #Sector Inquiry #EU Commission #Enforcement of Competition Rules #Competition Policy

목차

등록된 정보가 없습니다.

참고문헌 (50)

참고문헌 신청
Neil Lunt / 2017 / 고령화시 영국 국가보건의료서비스(NHS)의 과제와 전망 / 국제사회보장리뷰 1(1):7~18 google schola 공정거래위원회 / 2008 / EU의 경쟁법 판례분석 google schola 공정거래위원회 / 2009 / 제약산업, 가격․품질이 아닌 판촉경쟁이 치열한 규제산업 -공정위, 제약산업 경쟁정책보고서 발간 google schola 공정거래위원회 / 2009 / 해외경쟁정책동향 제10호 google schola 공정거래위원회 / 2010 / 주요 제약사에 대한 지식재산권 관련 서면 실태조사 실시 google schola

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0